Science Explorer Back to mapMap
Discussion
Company · Gaithersburg · United States

GlycoMimetics (United States)

glycomimetics.comROR OpenAlex
Research works
51
▼ 89% vs 2018-21
Citations
1k
20.3 per fractional work
Top-10% rate
3.7%
all institutions 10.0%
Open access
21%
world 40%
International
23%
world 18%
GlycoMimetics (United States)

Not ranked overall: GlycoMimetics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does GlycoMimetics (United States) work in?

In all years, 62% of research at GlycoMimetics (United States) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (62%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (10%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 31 fractional works · 61.9% of its workMedicine: 31 fractional works · 61.6% of its workImmunology and Allergy: 8 fractional works · 15.6% of its workOncology: 7 fractional works · 14.6% of its workHematology: 7 fractional works · 13.7% of its workGenetics: 2 fractional works · 4.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.3% of its workEmergency Medicine: 1 fractional works · 2.1% of its workInternal Medicine: 1 fractional works · 1.4% of its workPharmacology: 1 fractional works · 1.4% of its workEpidemiology: 0 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.2% of its workPathology and Forensic Medicine: 0 fractional works · 0.2% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workRheumatology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.2% of its workGeneral Health Professions: 0 fractional works · 0.2% of its workLife Sciences: 18 fractional works · 34.7% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 24.8% of its workMolecular Biology: 8 fractional works · 16.5% of its workCancer Research: 1 fractional works · 2.9% of its workBiotechnology: 1 fractional works · 1.8% of its workCell Biology: 1 fractional works · 1.6% of its workGenetics: 1 fractional works · 1.6% of its workBiochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 5 fractional works · 9.8% of its workImmunology: 5 fractional works · 9.8% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workPhysical Sciences: 2 fractional works · 3.4% of its workChemistry: 1 fractional works · 2.3% of its workOrganic Chemistry: 1 fractional works · 2.3% of its workMaterials Science: 0 fractional works · 0.9% of its workMaterials Chemistry: 0 fractional works · 0.9% of its workEnvironmental Science: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.1% of its workALL ITS WORKGlycoMimetics(United States)51fractional works, all years
Life Sciences35%Physical Sciences3%Health Sciences62%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Medicine3161.6%
    2. Health Professions00.2%
    1. Biochemistry, Genetics and Molecular Biology1324.8%
    2. Immunology and Microbiology59.8%
    3. Agricultural and Biological Sciences00.2%
    1. Chemistry12.3%
    2. Materials Science00.9%
    3. Environmental Science00.2%
    4. Engineering00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at GlycoMimetics (United States)?

Ranked on the quality score, John L. Magnani, William E. Fogler and Helen M Thackray lead among researchers whose main affiliation is GlycoMimetics (United States).

  1. 1 John L. Magnani United States · #689,557 worldwide 8.1k citations · 189 works
  2. 2 William E. Fogler United States · #1,509,511 worldwide 4.7k citations · 144 works
  3. 3 Helen M Thackray United States · #1,574,153 worldwide 1.1k citations · 48 works
  4. 4 Theodore A Smith United States · #2,476,037 worldwide 1.8k citations · 77 works
All ranked researchers at GlycoMimetics (United States)

What are the most cited papers from GlycoMimetics (United States)?

The most cited paper from GlycoMimetics (United States) is "Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance" (Ingrid G. Winkler, Valérie Barbier, Bianca Nowlan et al., 2012), with 434 citations. Next come "Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis" (269) and "Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone" (244).

Most cited papers
#PaperReleasedCitations
1 Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance Ingrid G. Winkler, Valérie Barbier, Bianca Nowlan et al. · Nature Medicine 21 Oct 2012 434
2 Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis Mark Esposito, Nandini Mondal, Todd M. Greco et al. · Nature Cell Biology Open access 15 Apr 2019 269
3 Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone Trevor T. Price, Monika Leigh Burness, Ayelet Sivan et al. · Science Translational Medicine Open access 25 May 2016 244
4 GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice Jungshan Chang, John T. Patton, Arun K. Sarkar et al. · Blood Open access 27 May 2010 238
5 Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use Marilyn J. Telen, Ted Wun, Timothy L. McCavit et al. · Blood Open access 2 Mar 2015 208
All 99 most cited papers, with filters and sorting

Which keywords describe research at GlycoMimetics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Angiogenesis, Extracellular Matrix, Cell Adhesion, Integrins, Therapeutic Targets and Cell Migration.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation20▲ 17×17 topics
  2. Cancer15▲ 21×14 topics
  3. Angiogenesis14▲ 70×6 topics
  4. Extracellular Matrix8▲ 69×2 topics
  5. Cell Adhesion8▲ 180×1 topic
  6. Integrins8▲ 267×1 topic
  7. Therapeutic Targets5▲ 42×2 topics
  8. Cell Migration5▲ 107×2 topics
  9. Cancer Metastasis4▲ 282×1 topic
  10. Chemokine Receptors4▲ 563×1 topic
  11. Hematopoietic Stem Cells4▲ 76×3 topics
  12. Prognostic Factors4▲ 17×4 topics
  13. Glycosylation4▲ 34×2 topics
  14. AML3▲ 136×1 topic
  15. Acute Myeloid Leukemia3▲ 136×1 topic
  16. Therapeutics3▲ 37×2 topics
  17. Glycans3▲ 64×1 topic
  18. Immune System3▲ 16×1 topic
  19. Immunity3▲ 15×3 topics
  20. Proteasome Inhibitors2▲ 61×2 topics
  21. Minimal Residual Disease2▲ 63×2 topics
  22. Diagnosis Criteria2▲ 131×1 topic
  23. International Myeloma Working Group2▲ 131×1 topic
  24. VEGF2▲ 111×1 topic
  25. endothelial progenitor cells2▲ 111×1 topic
  26. Innate Immunity2▲ 9.0×2 topics
  27. Metabolism2▲ 5.0×3 topics
  28. Tumor Microenvironment2▲ 8.2×4 topics
  29. Activation1▲ 76×1 topic
  30. Autoimmunity1▲ 13×3 topics
  31. Cancer Immunotherapy1▲ 18×2 topics
  32. Dendritic Cells1▲ 22×2 topics
  33. Macrophage1▲ 47×1 topic
  34. Fc Receptors1▲ 23×1 topic
  35. Therapeutic Antibodies1▲ 18×1 topic
  36. Antigen Presentation1▲ 22×1 topic
  37. Antithrombotic Therapy1▲ 21×2 topics
  38. Diagnostic Algorithm1▲ 35×2 topics
  39. Sickle-cell Disease1▲ 44×1 topic
  40. Tumor Antigen1▲ 27×1 topic

Which research topics does GlycoMimetics (United States) publish most on?

By volume in 2022-now: Cell Adhesion Molecules Research, Angiogenesis and VEGF in Cancer, Acute Myeloid Leukemia Research and S100 Proteins and Annexins.

Cell Adhesion Molecules …0Cell Adhesion Molecules Research: 0 fractional worksAngiogenesis and VEGF in…0Angiogenesis and VEGF in Cancer: 0 fractional worksAcute Myeloid Leukemia R…0Acute Myeloid Leukemia Research: 0 fractional worksS100 Proteins and Annexins0S100 Proteins and Annexins: 0 fractional worksAnimal Genetics and Reproduction: 0 fractional worksCRISPR and Genetic Engineering: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksImmune cells in cancer: 0 fractional worksQuinazolinone synthesis and applications: 0 fractional worksVirus-based gene therapy research: 0 fractional works
Immunology and AllergyMolecular BiologyHematologyGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  2. 2 Angiogenesis and VEGF in Cancer Molecular Biology 0 works
  3. 3 Acute Myeloid Leukemia Research Hematology 0 works
  4. 4 S100 Proteins and Annexins Molecular Biology 0 works
  5. 5 Animal Genetics and Reproduction Genetics 0 works
  6. 6 CRISPR and Genetic Engineering Molecular Biology 0 works
  7. 7 HER2/EGFR in Cancer Research Oncology 0 works
  8. 8 Immune cells in cancer Immunology 0 works
  9. 9 Quinazolinone synthesis and applications Organic Chemistry 0 works
  10. 10 Virus-based gene therapy research Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available21.0%not open79.0%

World: 40% of research is openly available.

with international co-authors22.8%domestic only77.2%

World: 18% is written across borders.

How has GlycoMimetics (United States)'s research output changed?

Output in 2022-2025 was 89% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is GlycoMimetics (United States) as a percentage of every work published that year, 0.000016% in 2024.

still counting0.00010%0.00020%GlycoMimetics (United States)0.0000099% in 202520102020

Fractional works of GlycoMimetics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about GlycoMimetics (United States). Posts are plain text and can be reported.